Freezing tumors to boost immune attack in breast cancer
NCT ID NCT05806385
Summary
This study is testing if freezing a breast tumor (cryoablation) combined with an immunotherapy drug (pembrolizumab) can better train the body's immune system to fight triple-negative breast cancer. It will compare this new approach to standard treatment and freezing alone in 36 women with early-stage cancer. The main goal is to see if the combination leads to a stronger immune response and better tumor control.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.